Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cancer Therapy Advisor
Explore how high-dose hyperfractionated thoracic radiotherapy is setting new standards in LS-SCLC treatment.
Oncology, Medical October 17th 2023
Explore how the landscape of RCC treatment is evolving with a focus on inclusivity and patient-centric approaches.
The New England Journal of Medicine
The human monoclonal antibody could be the treatment polymyalgia rheumatica patients experiencing relapses during glucocorticoid tapering have been waiting for.
Internal Medicine October 11th 2023
Discover how esketamine nasal spray could significantly alter the treatment approach for patients suffering from treatment-resistant depression.
Psychiatry October 10th 2023
Oncology Learning Network
Discover why CPX-351 extends relapse-free survival but does not significantly alter overall survival in younger AML/MDS patients, as revealed by the UK NCRI AML19 trial.
Hematology October 9th 2023
DocWire News
Discover how STRIDE is setting new benchmarks in the treatment of unresectable hepatocellular carcinoma, offering both improved survival rates and a tolerable safety profile.
Hepatology October 9th 2023